Navigation Links
BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
Date:9/22/2008


Toronto Stock Exchange Symbol: MS

- US$10 million received based on the positive review of interim

analysis for international pivotal multiple sclerosis trial -

EDMONTON, Sept. 22 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that it has received the US$10 million milestone payment from its partner, Eli Lilly and Company.

The milestone payment is based on the previously announced positive review of the scheduled interim analysis of the Company's pivotal phase II/III Canadian and European trial (MAESTRO-01) of dirucotide (MBP8298) in patients with secondary progressive MS. The independent Data Safety Monitoring Board (DSMB) for the MAESTRO-01 trial recommended that the trial proceed to completion based on the interim analysis which included efficacy and safety data from the first 200 patients to complete the trial.

To date, BioMS has received a total of US$97 million in payments from Eli Lilly and Company, based on the licensing and development agreement for dirucotide (MBP8298). An additional $400 million in milestone payments are possible under the terms of the licensing agreement, in addition to escalating royalties on sales.

"We are pleased that our partner has recognized the outcome of the interim analysis as a significant positive event," said Kevin Giese, President and CEO of BioMS Medical. "We look forward to completing the MAESTRO-01 trial and reviewing the complete data set in the second half of 2009."

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide (MBP8298), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
2. BioMS Medical to present at UBS Global Life Sciences Conference
3. BioMS Medicals lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA
4. BioMS Medical announces its intention to renew a normal course issuer bid
5. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
6. BioMS Medical Announces Second Quarter 2008 Results
7. BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
8. BioMS Medical to present at BMO Healthcare Conference
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. BioMS Medical to present at Jefferies Healthcare Conference
11. BioMS Medical to present at 2008 BIO International Convention

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPharm...thecompanyisscheduledtopresentatthePiperJaffray21s...a.m.EasternTime(8:30a.m.PacificTime)attheNewYorkPa...andChiefExecutiveOfficer,isscheduledtoprovideanove...nddiscoveryprograms. ,, Aliveaudiowebcastofthep...
(Date:11/24/2009)...N,Italy,November24/PRNewswire/--HealthRoboticstoda...withagroupofselected,investors.ThisrecentlyformedT...oboticsCanada,Inc.andwillmarket,install,andsupport...cludesthe,revolutionaryproductofferingsi.v.STATION...Inc.willalsoprovideassistanceonan"asneeded,basis"t...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), th...hat China,s patent office is now the world,s leadi...emistry. China trailed Japan,s patent office, the ...nd the United States Patent and Trademark Office (...O in 2005, WIPO in 2006, and exceeded Japan for th...
(Date:11/23/2009)... CITY, Nov. 23, 2009 In a provocative new study, ...carbon dioxide emissions the major cause of globa... economy collapses or society builds the equivalen...t looks unlikely that there will be any substantia...eration in carbon dioxide emission rates," says th...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...t. 14 Dr. Eliane Gluckman, recognized,as a pionee...transplantation, has joined the team at CORD:USE C...complished physician as Dr. Gluckman join our,team...ORD:USE," says Edward,Guindi M.D., President and C...recognized as the pioneering physician,who perform...
...t. 14 LI-COR Biosciences introduces a,new, novel ...he Odyssey(R),Infrared Imaging system. The Odyssey...stained and fluoresces in the 700 and 800 nm chann... for use with polyacrylamide gels,and can be used ...ring,electrophoresis, to monitor transfer efficien...
...f the Office of National Drug Control Policy to Mo...icines Become Bad Drugs, FRAZER, Pa., Oct. 14 Ce...t is embarking on a national educational,program d...s, caregivers,and the public about the importance ... opioid medications. The initiative, When Good Med...
Other Biology Technology:CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team 2CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team 3LI-COR Introduces the Odyssey(R) Two-Color NIR Fluorescent Protein Molecular Weight Marker 2Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications 2
(Date:11/24/2009)... that keep weakened and flabby arteries from colla...nths, those stents are no longer needed -- once th...ry. Previously, doctors had no choice but to leave...Aviv University,s Department of Biomedical Enginee...form that carries drugs where they,re needed, then...
(Date:11/24/2009)...N ROUGE Antarctica has long held secrets of the e... recently, there has been very little information ...miles of ice for millions of years. Now, a team of... have been funded to the tune of $10 million doll... get to the bottom of things literally. These sci...
(Date:11/23/2009)...NATINew research presents strong evidence that the...th outdoor traffic-related pollution and indoor en...one or the other exposure alone. , Environment...ti (UC) College of Medicine have shown that childr...particles and indoor endotoxin during early life a...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Bullies have harassed 14 percent of workers over past 6 months 8718 1Bullies have harassed 14 percent of workers over past 6 months 8718 2WaveSense Reduces Diabetes Testing Cost by 50 25 47934 1WaveSense Reduces Diabetes Testing Cost by 50 25 47934 2The Rev Michael J OConnell Assumes Chairmanship of Hazelden Foundation Board of Trustees 47932 1The Rev Michael J OConnell Assumes Chairmanship of Hazelden Foundation Board of Trustees 47932 2
..., 2009 Gov. Rick Perry today announced the awardi...uston through the Texas Emerging Technology Fund (...ruited a top hormones researcher and his team to c...neration pharmaceuticals and medical technologies ...d The Methodist Hospital Research Institute (TMHRI...
...searchers at The University of Texas at Austin, in... completed the first high-resolution CT scan of th...an ancestor who lived 3.2 million years ago. , L...miere exhibit organized by the Houston Museum of N...thropology in the College of Liberal Arts, led the...
..., PhD, a professor of history at NJIT and a former...ent for the Humanities (NEH) Fellowship to edit a ... eighteenth-century Scottish writer. Boswell was b...her,s research focuses on the thought and culture ... will publish the book in its Research Series of t...
Other Biology News:Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 2Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 3Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 4Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant 5Famous fossil Lucy scanned at the University of Texas at Austin 2Famous fossil Lucy scanned at the University of Texas at Austin 3
Rabbit IgG ELISA Development Kit, SensiFlex with Fluorocillin Green 495/525 from Molecular Probes (Invitrogen)
Human TNF-alpha from BioVision
Mouse Anti-Bovine WC1 Monoclonal Antibody, FITC Conjugated from AbD Serotec
...ns the basic components required for the developme...binant Feline IL-10 in cell culture supernates and...run ELISAs on approximately fifteen 96-well plates... The assay is run as summarized in the General ELI...
Biology Products: